Operating Income (Loss) in USD of Medicus Pharma Ltd. from 2023 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Medicus Pharma Ltd. quarterly/annual Operating Income (Loss) history and growth rate from 2023 to Q3 2025.
  • Medicus Pharma Ltd. Operating Income (Loss) for the quarter ending September 30, 2025 was -$15.000.
  • Medicus Pharma Ltd. Operating Income (Loss) for the twelve months ending September 30, 2025 was -$14.7M.
  • Medicus Pharma Ltd. annual Operating Income (Loss) for 2024 was -$11.2M, a 136% decline from 2023.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)

Medicus Pharma Ltd. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$14.7M -$15* +$2.33M Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-14
Q2 2025 -$17.1M -$6.02M -$2.46M -69.3% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-11
Q1 2025 -$14.6M -$5.13M -$3.42M -200% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-12
Q4 2024 -$11.2M -$3.59M Oct 1, 2024 Dec 31, 2024 10-K 2025-03-28
Q3 2024 -$2.33M Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-14
Q2 2024 -$3.55M Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-11
Q1 2024 -$1.71M Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-12

Medicus Pharma Ltd. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$11.2M -$6.45M -136% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-28
2023 -$4.73M Jan 1, 2023 Dec 31, 2023 10-K 2025-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.